GlassScriptPhysician profile
Taylor Schuch
NPI 1265928113
$4,630.38
in general payments reported to CMS, 2019-2025
42 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $529 · 2021: $955 · 2022: $1,013 · 2023: $606 · 2024: $658 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $677.52 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $592.16 | 2021-2025 | Zepbound, Mounjaro, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.53 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $330.11 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $302.56 | 2024 | Synovasure Alpha Defensin, Biocue, A.L.P.S. |
| Regeneron Healthcare Solutions, INC. | $223.89 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $211.05 | 2022 | |
| Pfizer INC. | $201.15 | 2019-2023 | |
| Linvatec Corporation | $180.44 | 2024 | Biobrace 23mm |
| Janssen Pharmaceuticals, INC | $173.07 | 2021-2025 | Spravato |
| Gilead Sciences, INC. | $125.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $120.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.16 | 2019-2021 | |
| Abbvie INC. | $111.03 | 2020-2025 | Vraylar, Ubrelvy |
| Csl Behring | $99.47 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Schuch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.